Great Point Partners LLC Neurocrine Biosciences Inc Transaction History

Great Point Partners LLC

  • $152 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$75.79 - $100.07 $5.68 Million - $7.51 Million
75,000 New
75,000 $7.31 Million
Q2 2018

Aug 14, 2018
SELL
$75.3 - $105.99 $30.1 Million - $42.4 Million
-400,000 Closed
0 $0
Q4 2017

Feb 14, 2018
SELL
$58.53 - $77.59 $4.39 Million - $5.82 Million
-75,000 Reduced 15.79%
400,000 $31 Million
Q3 2017

Nov 14, 2017
BUY
$47.97 - $61.28 $22.8 Million - $29.1 Million
475,000
475,000 $29.1 Million

Others Institutions Holding NBIX

# of Institutions
655
Shares Held
96.6M
Call Options Held
282K
Put Options Held
281K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $10.6B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email